“…Similar to that, genes that are involved in dopamine metabolism and transport ( DRD3, SLC6A3, MTHFR ), also showed to pose a risk for PD (Wu Y.-L. et al, 2013 ; Zhai et al, 2014 ; Hassan et al, 2016 ), with particularly, dopamine receptor D3 ( DRD3 ) gene that has been implicated in EOPD patients (Hassan et al, 2016 ). Due to heterogeneity of PD, various other genes have also been associated with PD in one or two populations, including saitohin protein (Lu et al, 2014 ), vitamin D receptor (Gatto et al, 2016 ), semaphorin 5A (Yu et al, 2014 ), granulin (Chen Y. et al, 2016 ), histamine N-methyltransferase ( HNMT ) (Jiménez-Jiménez et al, 2016b ), Ras like without CAAX 2 (Lu Y. et al, 2015 ; Foo et al, 2017 ), syntaxin 1B, parkinson disease 16, FGF20 , glycoprotein nmb (International Parkinson's Disease Genomics and Wellcome Trust Case Control, 2011 ), serine/threonine kinase 39 (Foo et al, 2017 ) and huntingtin interacting protein 1 related ( HIP1R ) (Yu et al, 2015 ) genes. Among these genes, HNMT and HIP1R genes have been found to be implicated with the age-onset of the disease, specifically for HNMT in EOPD (Yang X. et al, 2015 ) whereas HIP1R gene in LOPD (Yu et al, 2015 ).…”